Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 826 results for "cadila pharmaceutical"

Cadila Healthcare: Strong triggers ahead
Business Standard India

Cadila Healthcare : RECALLS 19,536 BOTTLES OF COUGH CAPSULES I...

The US Food and Drug Administration (USFDA) has notified that Zydus Pharmaceuticals USA , the US subsidiary of Cadila Healthcare , has voluntarily recalled 19,536 bottles of benzonatate capsules. The drug indicated for the treatment ... 4 Traders, 3 weeks ago
Cadila recalls 19,536 bottles of cough treatment drug in US Business Standard India, 3 weeks ago
Cadila Healthcare: Strong triggers ahead Business Standard India, 3 weeks ago
[x]  

Cadila gains on launch of first biosimilar of Adalimumab

Cadila Healthcare, one of the leading pharmaceutical companies, witnessed a rise in share price on Wednesday after it lunched its first biosimilar of Adalimumab- the largest selling therapy. Developed by the researchers at the Zydus Research ...
 MyIris1 month ago India's Cadila launches first cheaper copy of world's top-selling drug  Yahoo! Finance1 month ago Cadila Pharmaceuticals Launches First Cheaper Copy Of World's Top-Selling Drug Humira  BioSpace1 month ago Cadila launches first cheaper version of a multi-billion dollar drug  VC Circle1 month ago
Rediff.com

Dy. CM and Industries Minister of Telangana appreciate Cadila Pharmaceuticals

This year, Cadila Pharmaceuticals, Ahmedabad is an active participant and has set up a large exhibition stall to showcase its global presence and strength in innovation.
 India Infoline1 week ago Cadila Warned by FDA for Foul API Batches and Data Integrity  FDA News3 weeks ago Top Corporate News of the day-19 November, 2014  India Infoline2 months ago Cadila Pharmaceuticals to set up SPV for funding innovation based startups  Economic Times2 months ago
[x]  
Rediff.com

Zydus's biosimilar product Adalimumab now accessible in India

Zydus Cadila, an innovative, global pharmaceutical company that discovers, develops, manufactures and market a broad range of healthcare therapies has announced the launch of the biosimilar of Adalimumab, the world's largest selling therapy. Zydus ...
 PharmaBiz1 month ago India's Zydus Cadila finds blood pressure med has embedded brown spots  FiercePharmaManufacturing1 month ago Oncology Manufacturing Line Project for Indian Pharmaceutical Manufacturer  Process Industry Informer2 months ago Pharma cos should learn to appreciate FDA norms: Experts  Rediff.com2 months ago
Financial Express

Pharma companies face price pressure in US market

The global financial services firm analysed the drug prices of six companies: Aurobindo Pharma, Cadila Healthcare, Dr Reddy's Laboratories and Lupin, apart from Ranbaxy and Sun Pharmaceutical Industries, which are on the way to be merged. An ...
 Financial Express1 month ago

Cadila Pharmaceuticals organises innovation conclave IAMICON 2014

The conclave will focus on advances in the treatment of tuberculosis and cardiovascular diseases
 Business Standard2 months ago

Zydus Cadila initiates Phase III nonalcoholic steatohepatitis trial

Zydus Cadila, a pharmaceutical company, has initiated Phase III clinical trials to study the effect of Saroglitazar in adult nonalcoholic steatohepatitis, or NASH, patients. The Phase III trial will be of 52 week duration and will study the efficacy ...
 Individual.com2 weeks ago Zydus begins Phase - III study of Saroglitazar in NASH, a liver disease caused by obesity, diabetes and lipid disorders  PipelineReview2 weeks ago Pieris Initiates Phase I Clinical Trial for Anticalin(R) to Treat Anemia Marketwired  Yahoo! Finance1 month ago
Global Information Inc

Active Pharmaceutical Ingredients (API) Market in India 2015-2019: Key Vendors are Aurobindo Pharma, Cipla and Dr. Reddy's Laboratories

Dublin, Jan. 29, 2015 (GLOBE NEWSWIRE) -- Research and Markets ( http://www.researchandmarkets.com/research/s6tvl7/active ) has announced the addition of the "Active Pharmaceutical Ingredients (API) Market in India 2015-2019" report to their ...
 Market Pulse Navigator3 days ago Market Research Reports, Inc. (www.marketresearchreports.com): Active Pharmaceutical Ingredients (API) Market in India 2015-2019, New Report Launched  BusinessWeek1 week ago Pharmaceutical Newsletter - January 05 to 09, 2015  India Infoline3 weeks ago Pharmaceutical Newsletter - December 29, 2014 to January 02, 2015  India Infoline1 month ago
[x]  

Expect mixed bag performance in pharma space: KRChoksey

Q3FY15 Pharma Preview by KRChoksey Earnings expectation We expect our Pharma Universe to cumulatively post top line growth of 10% YoY majorly impacted by currency depreciation in Emerging markets. However key launches in US market by some of the ...
 Moneycontrol.com1 week ago Pharma set for healthy run this year  DNA India1 month ago
Business Standard India

Trio recall drugs in US

New Delhi, Dec. 30: Wockhardt, Cadila Healthcare and Hospira are voluntarily recalling certain drugs in the US. According to the information available on the website of the US Food and Drug Administration (USFDA), Wockhardt USA Inc is recalling ...
 Calcutta Telegraph1 month ago Three drugs firms recall select lot of drugs in the U.S.  The Hindu1 month ago Wockhardt, Cadila, Hospira recall drugs in the US  Business Standard India1 month ago Karnataka drugs control dept seizes 32 not of standard quality drugs during inspections of pharmacy outlets  PharmaBiz1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less